Literature DB >> 29949765

TGF-β Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma.

Karthiga Santhana Kumar1, Anuja Neve1, Ana S Guerreiro Stucklin2, Claudia M Kuzan-Fischer3, Elisabeth J Rushing4, Michael D Taylor5, Dimitra Tripolitsioti1, Lena Behrmann6, Daniel Kirschenbaum4, Michael A Grotzer7, Martin Baumgartner8.   

Abstract

The microenvironment shapes cell behavior and determines metastatic outcomes of tumors. We addressed how microenvironmental cues control tumor cell invasion in pediatric medulloblastoma (MB). We show that bFGF promotes MB tumor cell invasion through FGF receptor (FGFR) in vitro and that blockade of FGFR represses brain tissue infiltration in vivo. TGF-β regulates pro-migratory bFGF function in a context-dependent manner. Under low bFGF, the non-canonical TGF-β pathway causes ROCK activation and cortical translocation of ERK1/2, which antagonizes FGFR signaling by inactivating FGFR substrate 2 (FRS2), and promotes a contractile, non-motile phenotype. Under high bFGF, negative-feedback regulation of FRS2 by bFGF-induced ERK1/2 causes repression of the FGFR pathway. Under these conditions, TGF-β counters inactivation of FRS2 and restores pro-migratory signaling. These findings pinpoint coincidence detection of bFGF and TGF-β signaling by FRS2 as a mechanism that controls tumor cell invasion. Thus, targeting FRS2 represents an emerging strategy to abrogate aberrant FGFR signaling.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGFR1 signaling; FRS2; TGF-β signaling; bFGF; invasion; medulloblastoma; migration; organotypic cerebellum slice culture; tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 29949765     DOI: 10.1016/j.celrep.2018.05.083

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  10 in total

Review 1.  Targeting Angiogenic Factors for the Treatment of Medulloblastoma.

Authors:  Zahraa Saker; Mahdi Rizk; Hisham F Bahmad; Sanaa M Nabha
Journal:  Curr Treat Options Oncol       Date:  2022-04-12

2.  An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.

Authors:  Morgane Morabito; Magalie Larcher; Florence Mg Cavalli; Chloé Foray; Antoine Forget; Liliana Mirabal-Ortega; Mamy Andrianteranagna; Sabine Druillennec; Alexandra Garancher; Julien Masliah-Planchon; Sophie Leboucher; Abel Debalkew; Alessandro Raso; Olivier Delattre; Stéphanie Puget; François Doz; Michael D Taylor; Olivier Ayrault; Franck Bourdeaut; Alain Eychène; Celio Pouponnot
Journal:  EMBO Mol Med       Date:  2019-07-22       Impact factor: 12.137

3.  A new FGFR inhibitor disrupts the TGF-β1-induced fibrotic process.

Authors:  Mi-Hyoung Kim; Seung-Youn Jung; Kyung-Hee Song; Jeong-In Park; Jiyeon Ahn; Eun-Ho Kim; Jong Kuk Park; Sang-Gu Hwang; Hee-Jong Woo; Jie-Young Song
Journal:  J Cell Mol Med       Date:  2019-11-06       Impact factor: 5.310

4.  3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination.

Authors:  Sophie J Roper; Franziska Linke; Paul J Scotting; Beth Coyle
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

5.  Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma.

Authors:  Maximillian S Westphal; Eunjee Lee; Eric E Schadt; Giselle S Sholler; Jun Zhu
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

6.  Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma.

Authors:  Alexander P Landry; Nardin Samuel; Julian Spears; Zsolt Zador
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

7.  Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion.

Authors:  Jessica Migliavacca; Buket Züllig; Charles Capdeville; Michael A Grotzer; Martin Baumgartner
Journal:  Commun Biol       Date:  2022-08-08

8.  Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.

Authors:  Allison B Powell; Sridevi Yadavilli; Devin Saunders; Stacey Van Pelt; Elizabeth Chorvinsky; Rachel A Burga; Shuroug Albihani; Patrick J Hanley; Zhenhua Xu; Yanxin Pei; Eric S Yvon; Eugene I Hwang; Catherine M Bollard; Javad Nazarian; Conrad Russell Y Cruz
Journal:  J Transl Med       Date:  2019-09-23       Impact factor: 5.531

9.  FGF-induced LHX9 regulates the progression and metastasis of osteosarcoma via FRS2/TGF-β/β-catenin pathway.

Authors:  Shuang-Qing Li; Chao Tu; Lu Wan; Rui-Qi Chen; Zhi-Xi Duan; Xiao-Lei Ren; Zhi-Hong Li
Journal:  Cell Div       Date:  2019-11-25       Impact factor: 5.130

10.  Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion.

Authors:  Marc Thomas Schönholzer; Jessica Migliavacca; Elena Alvarez; Karthiga Santhana Kumar; Anuja Neve; Alexandre Gries; Min Ma; Michael A Grotzer; Martin Baumgartner
Journal:  Neoplasia       Date:  2020-08-17       Impact factor: 5.715

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.